Literature DB >> 34354056

Rhodaelectro-catalyzed access to chromones via formyl C-H activation towards peptide electro-labeling.

Maximilian Stangier1, Antonis M Messinis1, João C A Oliveira1, Hao Yu1, Lutz Ackermann2.   

Abstract

Chromones represent a privileged scaffold in medicinal chemistry and are an omnipresent structural motif in natural products. Chemically encoded non-natural peptidomimetics feature improved stability towards enzymatic degradation, cell permeability and binding affinity, translating into a considerable impact on pharmaceutical industry. Herein, a strategy for the sustainable assembly of chromones via electro-formyl C-H activation is presented. The rational design of the rhodaelectro-catalysis is guided by detailed mechanistic insights and provides versatile access to tyrosine-based fluorogenic peptidomimetics.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34354056     DOI: 10.1038/s41467-021-25005-8

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  31 in total

1.  Organometallic chemistry: C-H activation.

Authors:  Robert G Bergman
Journal:  Nature       Date:  2007-03-22       Impact factor: 49.962

2.  Rhodium-catalyzed oxidative coupling between salicylaldehydes and internal alkynes with C-H bond cleavage to produce 2,3-disubstituted chromones.

Authors:  Masaki Shimizu; Hayato Tsurugi; Tetsuya Satoh; Masahiro Miura
Journal:  Chem Asian J       Date:  2008-05-05

3.  Transition metal catalyzed alkene and alkyne hydroacylation.

Authors:  Michael C Willis
Journal:  Chem Rev       Date:  2010-02-10       Impact factor: 60.622

4.  Catalytic dehydrogenative cross-coupling: forming carbon-carbon bonds by oxidizing two carbon-hydrogen bonds.

Authors:  Charles S Yeung; Vy M Dong
Journal:  Chem Rev       Date:  2011-03-09       Impact factor: 60.622

5.  C-H bond activation enables the rapid construction and late-stage diversification of functional molecules.

Authors:  Joanna Wencel-Delord; Frank Glorius
Journal:  Nat Chem       Date:  2013-05       Impact factor: 24.427

6.  Iridium-catalyzed C-H borylation of heteroarenes: scope, regioselectivity, application to late-stage functionalization, and mechanism.

Authors:  Matthew A Larsen; John F Hartwig
Journal:  J Am Chem Soc       Date:  2014-03-06       Impact factor: 15.419

7.  Controllable Rh(III)-Catalyzed Annulation between Salicylaldehydes and Diazo Compounds: Divergent Synthesis of Chromones and Benzofurans.

Authors:  Peng Sun; Shang Gao; Chi Yang; Songjin Guo; Aijun Lin; Hequan Yao
Journal:  Org Lett       Date:  2016-12-01       Impact factor: 6.005

8.  Iridium-Catalyzed Aerobic Coupling of Salicylaldehydes with Alkynes: A Remarkable Switch of Oxacyclic Product.

Authors:  Shintaro Yamane; Tomoaki Hinoue; Yoshinosuke Usuki; Masumi Itazaki; Hiroshi Nakazawa; Yoshihiro Hayashi; Susumu Kawauchi; Masahiro Miura; Tetsuya Satoh
Journal:  Chemistry       Date:  2018-05-03       Impact factor: 5.236

Review 9.  Enantioselective C(sp3)‒H bond activation by chiral transition metal catalysts.

Authors:  Tyler G Saint-Denis; Ru-Yi Zhu; Gang Chen; Qing-Feng Wu; Jin-Quan Yu
Journal:  Science       Date:  2018-02-16       Impact factor: 47.728

10.  Mechanistic insights into the rhodium-catalyzed intramolecular ketone hydroacylation.

Authors:  Zengming Shen; Peter K Dornan; Hasan A Khan; Tom K Woo; Vy M Dong
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

View more
  2 in total

1.  Ruthenaelectro-catalyzed C-H acyloxylation for late-stage tyrosine and oligopeptide diversification.

Authors:  Xiaoyan Hou; Nikolaos Kaplaneris; Binbin Yuan; Johanna Frey; Tsuyoshi Ohyama; Antonis M Messinis; Lutz Ackermann
Journal:  Chem Sci       Date:  2022-02-25       Impact factor: 9.825

2.  Rhodaelectro-Catalyzed peri-Selective Direct Alkenylations with Weak O-Coordination Enabled by the Hydrogen Evolution Reaction (HER).

Authors:  Bartłomiej Sadowski; Binbin Yuan; Zhipeng Lin; Lutz Ackermann
Journal:  Angew Chem Int Ed Engl       Date:  2022-03-14       Impact factor: 16.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.